Annual Revenue
$5000.00
-$2.92 M-99.83%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual revenue is $5000.00, with the most recent change of -$2.92 million (-99.83%) on December 31, 2023.
- TCRT annual revenue is now -99.93% below its all-time high of $6.86 million, reached on December 31, 2016.
Performance
TCRT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- TCRT quarterly revenue is not available.
Performance
TCRT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- TCRT TTM revenue is not available.
Performance
TCRT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TCRT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.8% | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | -96.6% | - | - |
TCRT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.8% | at low | ||||
| 5 y | 5-year | -99.8% | at low | ||||
| alltime | all time | -99.9% | +194.1% |
Alaunos Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $4000.00(+300.0%) | $6000.00(0.0%) |
| Mar 2024 | - | $1000.00(0.0%) | $6000.00(+20.0%) |
| Dec 2023 | $5000.00(-99.8%) | $1000.00(-75.0%) | $5000.00(-99.8%) |
| Jun 2023 | - | $4000.00(-63.6%) | $2.93 M(+0.1%) |
| Dec 2022 | $2.92 M(+634.2%) | $11.00 K(-99.6%) | $2.92 M(+0.4%) |
| Sep 2022 | - | $2.91 M(+631.4%) | $2.91 M(+631.4%) |
| Dec 2021 | $398.00 K(+172.6%) | - | - |
| Sep 2021 | - | $398.00 K(+172.6%) | $398.00 K(-91.9%) |
| Dec 2018 | $146.00 K(-97.7%) | - | - |
| Mar 2018 | - | $146.00 K(-90.9%) | $4.94 M(-22.7%) |
| Dec 2017 | $6.39 M(-6.9%) | $1.60 M(-0.1%) | $6.39 M(0.0%) |
| Sep 2017 | - | $1.60 M(+0.1%) | $6.39 M(0.0%) |
| Jun 2017 | - | $1.60 M(0.0%) | $6.39 M(-1.5%) |
| Mar 2017 | - | $1.60 M(0.0%) | $6.49 M(-5.4%) |
| Dec 2016 | $6.86 M(+58.4%) | $1.60 M(-0.1%) | $6.86 M(-4.5%) |
| Sep 2016 | - | $1.60 M(-5.8%) | $7.18 M(-3.6%) |
| Jun 2016 | - | $1.70 M(-13.8%) | $7.45 M(+23.6%) |
| Mar 2016 | - | $1.97 M(+2.6%) | $6.03 M(+39.2%) |
| Dec 2015 | $4.33 M(+215.5%) | $1.92 M(+2.7%) | $4.33 M(+57.4%) |
| Sep 2015 | - | $1.87 M(+587.1%) | $2.75 M(+81.5%) |
| Jun 2015 | - | $272.00 K(0.0%) | $1.52 M(+5.0%) |
| Mar 2015 | - | $272.00 K(-20.0%) | $1.45 M(+5.2%) |
| Dec 2014 | $1.37 M | $340.00 K(-46.3%) | $1.37 M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | - | $633.00 K(+216.5%) | $1.23 M(+54.1%) |
| Jun 2014 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Mar 2014 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Dec 2013 | $800.00 K(0.0%) | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Sep 2013 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Jun 2013 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Mar 2013 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Dec 2012 | $800.00 K(+19.9%) | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Sep 2012 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Jun 2012 | - | $200.00 K(0.0%) | $800.00 K(0.0%) |
| Mar 2012 | - | $200.00 K(0.0%) | $800.00 K(+19.9%) |
| Dec 2011 | $667.00 K(>+9900.0%) | $200.00 K(0.0%) | $667.00 K(+42.8%) |
| Sep 2011 | - | $200.00 K(0.0%) | $467.00 K(+74.9%) |
| Jun 2011 | - | $200.00 K(+198.5%) | $267.00 K(+298.5%) |
| Mar 2011 | - | $67.00 K(+6600.0%) | $67.00 K(+1870.6%) |
| Dec 2002 | $2600.00(+52.9%) | - | - |
| Jun 2002 | - | $1000.00(-37.5%) | $3400.00(+13.3%) |
| Mar 2002 | - | $1600.00(+433.3%) | $3000.00(+76.5%) |
| Dec 2001 | $1700.00 | $300.00(-40.0%) | $1700.00(+21.4%) |
| Sep 2001 | - | $500.00(-16.7%) | $1400.00(-71.4%) |
| Jun 2001 | - | $600.00(+100.0%) | $4900.00(-41.0%) |
| Mar 2001 | - | $300.00(-92.5%) | $8300.00(+3.8%) |
| Sep 2000 | - | $4000.00(0.0%) | $8000.00(+100.0%) |
| Jun 2000 | - | $4000.00 | $4000.00 |
FAQ
- What is Alaunos Therapeutics annual revenue?
- What is the all time high annual revenue for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Alaunos Therapeutics?
- What is the all time high TTM revenue for Alaunos Therapeutics?
What is Alaunos Therapeutics annual revenue?
The current annual revenue of TCRT is $5000.00
What is the all time high annual revenue for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual revenue is $6.86 M
What is Alaunos Therapeutics annual revenue year-on-year change?
Over the past year, TCRT annual revenue has changed by -$2.92 M (-99.83%)
What is the all time high quarterly revenue for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly revenue is $2.91 M
What is the all time high TTM revenue for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM revenue is $7.45 M